-+ 0.00%
-+ 0.00%
-+ 0.00%

Avenue Therapeutics Q3 EPS $(1.92) Misses $(0.94) Estimate

Benzinga·11/14/2024 22:49:11
Listen to the news
Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(1.92) per share which missed the analyst consensus estimate of $(0.94) by 104.26 percent. This is a 139.51 percent decrease over earnings of $4.86 per share from the same period last year.